StonvexLoading…
StonvexStonvexStonvexCore line items from ECVT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 | Annual 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $723.51M | $204.91M | $176.06M | $143.11M |
Operating Income | $64.89M | $28.27M | $15.78M | $-981.00K |
Net Income | $-71.13M | $-79.25M | $5.99M | $-3.60M |
EPS (Diluted) | $-0.61 | $-0.69 | $0.05 | $-0.03 |
Total Assets | $1.26B | Not available | Not available | Not available |
Total Liabilities | $657.54M | Not available | Not available | Not available |
Cash & Equivalents | $197.19M | Not available | Not available | Not available |
Free Cash Flow OCF − CapEx | $69.89M | Not available | Not available | Not available |
Shares Outstanding | 111.81M | 114.87M | 116.54M | 117.26M |